Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-15 4:17 pm Purchase | 2023-05-05 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Venrock Healthcare Capital Partners III L.P. | 2,887,517 8.700% | 2,887,517 (New Position) | Filing History |
| 2023-02-14 08:32 am Purchase | 2022-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Deep Track Capital LP | 2,656,901 8.200% | 756,901 (+39.84%) | Filing History |
| 2023-02-09 09:07 am Sale | 2022-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | JANUS HENDERSON GROUP PLC JHG | 1,466,267 4.500% | -181,656 (-11.02%) | Filing History |
| 2023-02-08 4:15 pm Sale | 2022-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Kirn David | 2,022,498 6.200% | -11,877 (-0.58%) | Filing History |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | BlackRock Inc. BLK | 2,508,632 7.700% | 420,950 (+20.16%) | Filing History |
| 2022-06-21 4:53 pm Purchase | 2022-06-16 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | BIOTECHNOLOGY VALUE FUND L P | 4,007,413 12.400% | 2,001,551 (+99.79%) | Filing History |
| 2022-02-14 5:02 pm Unchanged | 2021-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | VIKING GLOBAL INVESTORS LP | 3,937,914 12.300% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:33 pm Purchase | 2021-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Kirn David | 2,034,375 6.300% | 34,375 (+1.72%) | Filing History |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | SCHAFFER DAVID | 901,215 2.800% | -1,098,785 (-54.94%) | Filing History |
| 2022-02-14 08:56 am Purchase | 2021-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Deep Track Capital LP | 1,900,000 5.910% | 100,000 (+5.56%) | Filing History |
| 2022-02-11 3:54 pm Sale | 2021-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | PFIZER INC PFE | 341,658 1.060% | -1,325,000 (-79.50%) | Filing History |
| 2022-02-11 3:19 pm Purchase | 2021-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | JANUS HENDERSON GROUP PLC JHG | 1,647,923 5.100% | 1,647,923 (New Position) | Filing History |
| 2022-02-09 09:09 am Sale | 2022-02-08 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | FMR LLC | 1,140,174 3.547% | -454,181 (-28.49%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | BlackRock Inc. BLK | 2,087,682 6.500% | 2,087,682 (New Position) | Filing History |
| 2021-11-04 5:02 pm Purchase | 2021-10-29 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Deep Track Capital LP | 1,800,000 5.690% | 1,800,000 (New Position) | Filing History |
| 2021-07-06 5:01 pm Purchase | 2021-06-25 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | BIOTECHNOLOGY VALUE FUND L P | 2,005,862 7.500% | 2,005,862 (New Position) | Filing History |